Trials / Completed
CompletedNCT02646566
Study of APD421 as PONV Treatment (Prior Prophylaxis)
Randomised, Double-blind, Placebo-controlled Study of APD421 (Amisulpride for IV Injection) as Treatment of Established Post-operative Nausea and Vomiting, in Patients Who Have Had Prior Prophylaxis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 705 (actual)
- Sponsor
- Acacia Pharma Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Double-blind, randomised, parallel-group, placebo-controlled, adaptive, seamless, dose-selecting study to compare the efficacy of APD421 to placebo as treatment of established PONV, in patients who have had prior PONV prophylaxis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | APD421 | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2016-01-05
- Last updated
- 2019-01-22
- Results posted
- 2018-12-19
Locations
8 sites across 3 countries: United States, France, Germany
Source: ClinicalTrials.gov record NCT02646566. Inclusion in this directory is not an endorsement.